|
1
|
Souza R, Jardim C and Humbert M:
Idiopathic pulmonary arterial hypertension. Semin Respir Crit Care
Med. 34:560–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo YH, Su LX, Guo N and Liu CT: Novel
therapy for idiopathic pulmonary arterial hypertension: Can
hepatocyte growth factor be beneficial? J Geriatr Cardiol.
9:211–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janczura M, Bochenek G, Nowobilski R,
Dropinski J, Kotula-Horowitz K, Laskowicz B, Stanisz A, Lelakowski
J and Domagala T: Correction: The relationship of metabolic
syndrome with stress, coronary heart disease and pulmonary function
- An occupational cohort-based study. PLoS One. 10:e01394082015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Runo JR and Loyd JE: Primary pulmonary
hypertension. Lancet. 361:1533–1544. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Patel RS and Ye S: Genetic determinants of
coronary heart disease: new discoveries and insights from
genome-wide association studies. Heart. 97:1463–1473. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lewczuk J: Pulmonary heart disease –
cardiologist's point of view. Pneumonol Alergol Pol. 80:541–545.
2012.In Polish.
|
|
7
|
Mikhail G, Chester AH, Gibbs JS, Borland
JA, Banner NR and Yacoub MH: Role of vasoactive mediators in
primary and secondary pulmonary hypertension. Am J Cardiol.
82:254–255. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han MK, McLaughlin VV, Criner GJ and
Martinez FJ: Pulmonary diseases and the heart. Circulation.
116:2992–3005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fihn SD, Gardin JM, Abrams J, Berra K,
Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC,
Hinderliter AL, et al: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS
guideline for the diagnosis and management of patients with stable
ischemic heart disease: A report of the American College of
Cardiology Foundation/American Heart Association task force on
practice guidelines, and the American College of Physicians
American Association for Thoracic Surgery, Preventive
Cardiovascular Nurses Association, Society for Cardiovascular
Angiography and Interventions, and Society of Thoracic Surgeons.
Circulation. 126:e354–e471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Csermely P, Korcsmáros T, Kiss HJ, London
G and Nussinov R: Structure and dynamics of molecular networks: A
novel paradigm of drug discovery: A comprehensive review. Pharmacol
Ther. 138:333–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ichihara S, Yamamoto K, Asano H, Nakatochi
M, Sukegawa M, Ichihara G, Izawa H, Hirashiki A, Takatsu F, Umeda
H, et al: Identification of a glutamic acid repeat polymerphism of
ALMS1 as a novel genetic risk marker for early-onset myocardial
infarction by genome-wide linkage analysis. Circ Cardiovasc Genet.
6:569–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eaton CB, Gramling R, Parker DR, Roberts
MB, Lu B and Ridker PM: Prospective association of vascular
endothelial growth factor-A (VEGF-A) with coronary heart disease
mortality in southeastern New England. Atherosclerosis.
200:221–227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hamosh A, Scott AF, Amberger JS, Bocchini
CA, Valle D and McKusick VA: Online mendelian inheritance in Man
(OMIM), a knowledgebase of human genes and genetic disorders.
Nucleic Acids Res. 30:52–55. 2002. View Article : Google Scholar :
|
|
14
|
Mattingly CJ, Colby GT, Forrest JN and
Boyer JL: The Comparative Toxicogenomics Database (CTD). Environ
Health Perspect. 111:793–795. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
van der Wal AC: Coronary artery pathology.
Heart. 93:1484–1489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cooke GE, Doshi A and Binkley PF:
Endothelial nitric oxide synthase gene: Prospects for treatment of
heart disease. Pharmacogenomics. 8:1723–1734. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Colombo MG, Paradossi U, Andreassi MG,
Botto N, Manfredi S, Masetti S, Biagini A and Clerico A:
Endothelial nitric oxide synthase gene polymorphisms and risk of
coronary artery disease. Clin Chem. 49:389–395. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aytekin M, Aulak KS, Haserodt S,
Chakravarti R, Cody J, Minai OA and Dweik RA: Abnormal platelet
aggregation in idiopathic pulmonary arterial hypertension: Role of
nitric oxide. Am J Physiol Lung Cell Mol Physiol. 302:L512–L520.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Orte C, Polak JM, Haworth SG, Yacoub MH
and Morrell NW: Expression of pulmonary vascular
angiotensin-converting enzyme in primary and secondary plexiform
pulmonary hypertension. J Pathol. 192:379–384. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mattu RK, Needham EW, Galton DJ, Frangos
E, Clark AJ and Caulfield M: A DNA Variant at the
angiotensin-converting enzyme gene locus associates with coronary
artery disease in the caerphilly heart study. Circulation.
91:270–274. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanno S, Wu YJ, Lee PC, Billiar TR and Ho
C: Angiotensin-converting enzyme inhibitor preserves p21 and
endothelial nitric oxide synthase expression in
monocrotaline-induced pulmonary arterial hypertension in rats.
Circulation. 104:945–950. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCullough PA: Chronic kidney disease:
Tipping the scale to the benefit of angiotensin-converting enzyme
inhibitors in patients with coronary artery disease. Circulation.
114:6–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zisman LS, Asano K, Dutcher DL, Ferdensi
A, Robertson AD, Jenkin M, Bush EW, Bohlmeyer T, Perryman MB and
Bristow MR: Differential regulation of cardiac angiotensin
converting enzyme binding sites and AT1 receptor density in the
failing human heart. Circulation. 98:1735–1741. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bietrix F, Lombardo E, van Roomen CP,
Ottenhoff R, Vos M, Rensen PC, Verhoeven AJ, Aerts JM and Groen AK:
Inhibition of glycosphingolipid synthesis induces a profound
reduction of plasma cholesterol and inhibits atherosclerosis
development in APOE*3 Leiden and low-density lipoprotein
receptor−/−mice. Arterioscler Thromb Vasc Biol. 30:931–937. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peters SA, Singhateh Y, Mackay D, Huxley
RR and Woodward M: Total cholesterol as a risk factor for coronary
heart disease and stroke in women compared with men: A systematic
review and meta-analysis. Atherosclerosis. 248:123–131. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chapman MJ: Therapeutic elevation of
HDL-cholesterol to prevent atherosclerosis and coronary heart
disease. Pharmacol Ther. 111:893–908. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ninomiya T, Nagata M, Hata J, Hirakawa Y,
Ozawa M, Yoshida D, Ohara T, Kishimoto H, Mukai N, Fukuhara M, et
al: Association between ratio of serum eicosapentaenoic acid to
arachidonic acid and risk of cardiovascular disease: The Hisayama
Study. Atherosclerosis. 231:261–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ball SK, Field MC and Tippins JR:
Regulation of thromboxane receptor signaling at multiple levels by
oxidative stress-induced stabilization, relocation and enhanced
responsiveness. PLoS One. 5:e127982010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hirenallur-S DK, Detweiler ND, Haworth ST,
Leming JT, Gordon JB and Rusch NJ: Furegrelate, a thromboxane
synthase inhibitor, blunts the development of pulmonary arterial
hypertension in neonatal piglets. Pulm Circ. 2:193–200. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sobieszczyk P, Fishbein MC and Goldhaber
SZ: Acute pulmonary embolism: Don't ignore the platelet.
Circulation. 106:1748–1749. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goldhaber SZ and Elliott CG: Acute
pulmonary embolism: Part I epidemiology, pathophysiology, and
diagnosis. Circulation. 108:2726–2729. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tian W, Jiang X, Sung YK, Qian J, Yuan K
and Nicolls MR: Leukotrienes in pulmonary arterial hypertension.
Immunol Res. 58:387–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nair J, Shanker J, Jambunathan S, Arvind P
and Kakkar VV: Expression analysis of leukotriene-inflammatory gene
interaction network in patients with coronary artery disease. J
Atheroscler Thromb. 21:329–345. 2014. View Article : Google Scholar
|
|
34
|
Prasad K and Kalra J: Oxygen free radicals
and heart failure. Angiology. 39:417–420. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim D, Kwon YK and Cho KH: Coupled
positive and negative feedback circuits form an essential building
block of cellular signaling pathways. Bioessays. 29:85–90. 2007.
View Article : Google Scholar
|
|
36
|
Karastergiou K, Evans I, Ogston N, Miheisi
N, Nair D, Kaski JC, Jahangiri M and Mohamed-Ali V: Epicardial
adipokines in obesity and coronary artery disease induce
atherogenic changes in monocytes and endothelial cells.
Arterioscler Thromb Vasc Biol. 30:1340–1346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu HF, Qi XW, Ma LL, Yao DK and Wang L:
Atorvastatin improves endothelial progenitor cell function and
reduces pulmonary hypertension in patients with chronic pulmonary
heart disease. Exp Clin Cardiol. 18:e40–e43. 2013.PubMed/NCBI
|
|
38
|
Crosswhite P and Sun Z: Molecular
mechanisms of pulmonary arterial remodeling. Mol Med. 20:191–201.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hamidi SA, Prabhakar S and Said SI:
Enhancement of pulmonary vascular remodelling and inflammatory
genes with VIP gene deletion. Eur Respir J. 31:135–139. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Heusch G, Schulz R and Erbel R:
Inflammatory markers in coronary heart disease: Coronary vascular
versus myocardial origin? Circulation. 108:e42003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
de Nigris F, Youssef T, Ciafré S, Franconi
F, Anania V, Condorelli G, Palinski W and Napoli C: Evidence for
oxidative activation of c-Myc-Dependent nuclear signaling in human
coronary smooth muscle cells and in early lesions of watanabe
heritable hyperlipidemic rabbits: Protective effects of vitamin E.
Circulation. 102:2111–2117. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fraisse A, Jais X, Schleich JM, di Filippo
S, Maragnès P, Beghetti M, Gressin V, Voisin M, Dauphin C, Clerson
P, et al: Characteristics and prospective 2-year follow-up of
children with pulmonary arterial hypertension in France. Arch
Cardiovasc Dis. 103:66–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Page IH, Berrettoni JN, Butkus A and Sones
FM Jr: Prediction of coronary heart disease based on clinical
suspicion, age, total cholesterol, and triglyceride. Circulation.
42:625–645. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vaughan CJ, Gotto AM Jr and Basson CT: The
evolving role of statins in the management of atherosclerosis. J Am
Coll Cardiol. 35:1–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maron DJ, Fazio S and Linton MF: Current
perspectives on statins. Circulation. 101:207–213. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yusuf S, Sleight P, Pogue J, Bosch J,
Davies R and Dagenais G: Effects of an angiotensin
converting-enzyme inhibitor, ramipril, on cardiovascular events in
high-risk patients. The heart outcomes prevention evaluation study
investigators. N Engl J Med. 342:145–153. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yusuf S, Sleight P, Pogue J, Bosch J,
Davies R and Dagenais G: Cardiac rehabilitation and secondary
prevention of coronary heart disease. Circulation. 111:369–376.
2005. View Article : Google Scholar
|
|
48
|
Jeffery TK and Wanstall JC: Pulmonary
vascular remodeling: A target for therapeutic intervention in
pulmonary hypertension. Pharmacol Ther. 92:1–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Budhiraja R, Tuder RM and Hassoun PM:
Endothelial dysfunction in pulmonary hypertension. Circulation.
109:159–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rich S and McLaughlin VV: Endothelin
receptor blockers in cardiovascular disease. Circulation.
108:2184–2190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Minamino T, Kurihara H, Takahashi M,
Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K and
Yazaki Y: Endothelin-converting enzyme expression in the rat
vascular injury model and human coronary atherosclerosis.
Circulation. 95:221–230. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Stewart DJ, Kubac G, Costello KB and
Cernacek P: Increased plasma endothelin-1 in the early hours of
acute myocardial infarction. J Am Coll Cardiol. 18:38–43. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Reriani M, Raichlin E, Prasad A, Mathew V,
Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO and Lerman A:
Long-term administration of endothelin receptor antagonist improves
coronary endothelial function in patients with early
atherosclerosis. Circulation. 122:958–966. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Blanco-Colio LM: TWEAK/Fn14 Axis: A
promising target for the treatment of cardiovascular diseases.
Front Immunol. 5:32014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang S, Fantozzi I, Tigno DD, Yi ES,
Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ and
Yuan JX: Bone morphogenetic proteins induce apoptosis in human
pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol
Physiol. 285:L740–L754. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Merklinger SL, Jones PL, Martinez EC and
Rabinovitch M: Epidermal growth factor receptor blockade mediates
smooth muscle cell apoptosis and improves survival in rats with
pulmonary hypertension. Circulation. 112:423–431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Strauer BE, Brehm M, Zeus T, Bartsch T,
Schannwell C, Antke C, Sorg RV, Kögler G, Wernet P, Müller HW and
Köstering M: Regeneration of human infarcted heart muscle by
intracoronary autologous bone marrow cell transplantation in
chronic coronary heart disease: The IACT-study. J Am Coll Cardiol.
46:1651–1658. 2005. View Article : Google Scholar : PubMed/NCBI
|
